SCHEMBL13249045

SCHEMBL13249045

c1ccc(-c2c3ccccc3c(-c3ccccc3)c3c2ccc2cc(-n4c5ccccc5c5ccccc54)ccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ KMT2A Q03164 3/20 0.38
▸ ALOX5 P09917 1/20 0.34
▸ EDNRB P24530 1/20 0.33
▸ EDNRA P25101 1/20 0.33
▸ ESR1 P03372 4/20 0.33
▸ ESR2 Q92731 4/20 0.33
▸ NQO2 P16083 1/20 0.33
▸ HDAC4 P56524 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ HSD17B1 P14061 1/20 0.32
▸ CYP2B6 P20813 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ IL1R1 P14778 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17718068 0.89 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AESR1
SCHEMBL17718058 0.88 KDM4E (0.44) L3MBTL1KDM4EATMKMT2AALOX5
SCHEMBL26813184 0.84 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2AALOX5
SCHEMBL26813185 0.84 L3MBTL1 (0.46) L3MBTL1KDM4EATMKMT2AALOX5
SCHEMBL9890897 0.84 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL17718064 0.83 ESR1 (0.36) L3MBTL1KDM4EATMKMT2AEDNRB
SCHEMBL13428282 0.83 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AALOX5
SCHEMBL1925373 0.83 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AALOX5
SCHEMBL12928330 0.83 L3MBTL1 (0.53) L3MBTL1KDM4EATMKMT2AALOX5
SCHEMBL13669449 0.83 KDM4E (0.43) L3MBTL1KDM4EATMKMT2AEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8986852-B2 Benzanthracene derivatives for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-24 — — US disclosed
US-8986852-B2 Benzanthracene derivatives for organic electroluminescent devices MERCK PATENT GMBH (DE) 2015-03-24 — — US disclosed
US-20100187505-A1 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES IDEMITSU KOSAN CO., LTD. (JP) 2010-07-29 — — US disclosed
US-20100187505-A1 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES IDEMITSU KOSAN CO., LTD. (JP) 2010-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100187505-A1 BENZANTHRACENE DERIVATIVES FOR ORGANIC ELECTROLUMINESCENT DEVICES KCNT1, KCNC1, TMEM109 L3MBTL1 2155/4885KDM4E 1859/4885ATM 3633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback